{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:49:44Z","timestamp":1775278184538,"version":"3.50.1"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7010-25","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T22:08:45Z","timestamp":1774908525000},"source":"Crossref","is-referenced-by-count":0,"title":["Unilateral Renal Transcatheter Arterial Embolization Enabling the Continuation of Peritoneal Dialysis In Autosomal Dominant Polycystic Kidney Disease"],"prefix":"10.2169","author":[{"given":"Ayaka","family":"Kamada","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiya","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuo","family":"Hirose","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Japan"},{"name":"Division of Integrative Renal Replacement Therapy, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Ito","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Ishiyama","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyoshi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Matsuura","sequence":"additional","affiliation":[{"name":"Division of Radiology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Yamada","sequence":"additional","affiliation":[{"name":"Division of Radiology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takefumi","family":"Mori","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Japan"},{"name":"Division of Integrative Renal Replacement Therapy, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Suwabe T, Ubara Y, Oba Y, et al. Changes in kidney and liver volumes in patients with autosomal dominant polycystic kidney disease before and after dialysis initiation. Mayo Clin Proc Innov Qual Outcomes 7: 69-80, 2023.","DOI":"10.1016\/j.mayocpiqo.2022.12.005"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Jankowska M, Chmielewski M, Lichodziejewska-Niemierko M, Jagodzinski P, Rutktowski B. Peritoneal dialysis as a treatment option in autosomal dominant polycystic kidney disease. Int Urol Nephrol 47: 1739-1744, 2015.","DOI":"10.1007\/s11255-015-1087-9"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Couchoud C, Savoye E, Frimat L, et al. Variability in case mix and peritoneal dialysis selection in fifty-nine French districts. Perit Dial Int 28: 509-517, 2008.","DOI":"10.1177\/089686080802800515"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ubara Y, Tagami T, Sawa N, et al. Renal contraction therapy for enlarged polycystic kidneys by transcatheter arterial embolization in hemodialysis patients. Am J Kidney Dis 39: 571-579, 2002.","DOI":"10.1053\/ajkd.2002.31407"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Suwabe T, Ubara Y, Sekine A, et al. Effect of renal transcatheter arterial embolization on quality of life in patients with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 32: 1176-1183, 2017.","DOI":"10.1093\/ndt\/gfx186"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hamanoue S, Hoshino J, Suwabe T, et al. Peritoneal dialysis is limited by kidney and liver volume in autosomal dominant polycystic kidney disease. Ther Apher Dial 19: 207-211, 2015.","DOI":"10.1111\/1744-9987.12272"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Suwabe T, Ubara Y, Mise K, et al. Suitability of patients with autosomal dominant polycystic kidney disease for renal transcatheter arterial embolization. J Am Soc Nephrol 27: 2177-2187, 2016.","DOI":"10.1681\/ASN.2015010067"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Suwabe T, Oguro M, Ubara Y, et al. Repetitive refractory renal cyst infection in autosomal dominant polycystic kidney disease for which renal transcatheter arterial embolization was effective in preventing recurrence. Intern Med 60: 3261-3265, 2021.","DOI":"10.2169\/internalmedicine.6974-20"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ye W, Voss MD, Athreya S. Volume Reduction in Enlarged Kidneys in autosomal dominant polycystic kidney disease (ADPKD) Prior to Renal Transplant with transcatheter arterial embolization (TAE): a systematic review and meta-analysis. Cardiovasc Intervent Radiol 41: 828-834, 2018.","DOI":"10.1007\/s00270-018-1890-7"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Pierre M, Moreau K, Braconnier A, et al. Unilateral nephrectomy versus renal arterial Embolization and technique survival in peritoneal dialysis patients with Autosomal dominant Polycystic kidney disease. Nephrol Dial Transplant 35: 320-327, 2020.","DOI":"10.1093\/ndt\/gfz200"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ubara Y, Suwabe T, Sawa N. Transcatheter arterial embolization therapy in patients with polycystic kidney disease and liver disease: review from case series. Clin Exp Nephrol 29: 29-38, 2025.","DOI":"10.1007\/s10157-024-02597-1"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Covic A, Bammens B, Lobbedez T, et al. Educating end-stage renal disease patients on dialysis modality selection: clinical advice from the European renal best practice (ERBP) advisory board. Nephrol Dial Transplant 25: 1757-1759, 2010.","DOI":"10.1093\/ndt\/gfq206"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Moist LM, Port FK, Orzol SM, et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 11: 556-564, 2000.","DOI":"10.1681\/ASN.V113556"},{"key":"14","unstructured":"14. Barman TK, Roy S, Hossain SM, Salahuddin AZ, Huq MO. Comparison of cardiac outcome of continuous ambulatory peritoneal dialysis & hemodialysis in CKD5 patients with heart failure. Mymensingh Medical Journal: MMJ 29: 793-799, 2020."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Schrier RW, Abebe KZ, Perrone RD, et al. Blood pressure in early autosomal dominant polycystic kidney disease. N Engl J Med 371: 2255-2266, 2014.","DOI":"10.1056\/NEJMoa1402685"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Muraki I. Muscle mass assessment in sarcopenia: A narrative review. JMA J 6: 381-386, 2023.","DOI":"10.31662\/jmaj.2023-0053"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Seidell JC, Bakker CJ, van der Kooy K. Imaging techniques for measuring adipose-tissue distribution comparison between computed tomography and 1.5-T magnetic resonance. Am J Clin Nutr 51: 953-957, 1990.","DOI":"10.1093\/ajcn\/51.6.953"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Amini B, Boyle SP, Boutin RD, Lenchik L. Approaches to assessment of muscle mass and myosteatosis on computed tomography: a systematic review. J Gerontol A Biol Sci Med Sci 74: 1671-1678, 2019.","DOI":"10.1093\/gerona\/glz034"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Ng JK, Lau SL, Chan GC, Tian N, Li PK. Nutritional assessments by bioimpedance technique in dialysis patients. Nutrients 16: 15, 2023.","DOI":"10.3390\/nu16010015"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Xu L, Ng JK, Chan GC, Fung WW, Chow K, Szeto CC. Early change in lean tissue mass after peritoneal dialysis: prevalence, risk factors, and clinical implications. BMC Nephrol 26: 411, 2025.","DOI":"10.1186\/s12882-025-04350-6"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Yeun JY, Kaysen GA. Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients. Am J Kidney Dis 30: 923-927, 1997.","DOI":"10.1016\/S0272-6386(97)90105-0"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Stenvinkel P. Inflammation in end-stage renal disease: the hidden enemy. Nephrology (Carlton) 11: 36-41, 2006.","DOI":"10.1111\/j.1440-1797.2006.00541.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7010-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T03:55:37Z","timestamp":1775274937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7010-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":22,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7010-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7010-25"}}